Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
HIV Outcomes @HIVOutcomes
Wed, 01/13/2021 - 11:35
RT @JVLazarus: At 10.00 the general members meeting of @HIVOutcomes will start. Looking forward to presenting our work together with @ProfJ…
Jeffrey V. Lazarus @JVLazarus
Wed, 01/13/2021 - 10:22
At 10.00 the general members meeting of @HIVOutcomes will start. Looking forward to presenting our work together wi… https://t.co/iQ2ajPu6i6